Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.
about
A-to-I editing of coding and non-coding RNAs by ADARsTo edit or not to edit: regulation of ADAR editing specificity and efficiencyAdenosine-to-inosine RNA editing and human diseaseThe emerging landscape of small nucleolar RNAs in cell biologyThe molecular basis of cognitive deficits in pervasive developmental disordersQuantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disordersRapid and dynamic transcriptome regulation by RNA editing and RNA modificationsDisruption of copper homeostasis due to a mutation of Atp7a delays the onset of prion diseaseThe dynamic epitranscriptome: A to I editing modulates genetic informationTranscript diversification in the nervous system: a to I RNA editing in CNS function and disease developmentUnderstanding RNA modifications: the promises and technological bottlenecks of the 'epitranscriptome'.Editing of neurotransmitter receptor and ion channel RNAs in the nervous systemMood, food, and obesity.Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments.Potent and selective inhibition of A-to-I RNA editing with 2'-O-methyl/locked nucleic acid-containing antisense oligoribonucleotides.Comparative RNA editing in autistic and neurotypical cerebella.Quantitative analysis of focused a-to-I RNA editing sites by ultra-high-throughput sequencing in psychiatric disorders.Prevention of 5-hydroxytryptamine2C receptor RNA editing and alternate splicing in C57BL/6 mice activates the hypothalamic-pituitary-adrenal axis and alters moodMolecular recognition of 6'-N-5-hexynoate kanamycin A and RNA 1x1 internal loops containing CA mismatches.Recognition of duplex RNA by the deaminase domain of the RNA editing enzyme ADAR2The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasisOligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development.Altered ADAR 2 equilibrium and 5HT(2C) R editing in the prefrontal cortex of ADAR 2 transgenic mice.Prader-Willi syndrome and autism spectrum disorders: an evolving story.Dynamic 5-HT2C receptor editing in a mouse model of obesity.RNA Structures as Mediators of Neurological Diseases and as Drug Targets.TPH2 G/T polymorphism is associated with hyperphagia, IQ, and internalizing problems in Prader-Willi syndrome.Hyperactive hypothalamus, motivated and non-distractible chronic overeating in ADAR2 transgenic mice.Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.Nucleoside analog studies indicate mechanistic differences between RNA-editing adenosine deaminases.Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.Serotonin and the regulation of mammalian energy balance.5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and AntagonistsReciprocal regulation of A-to-I RNA editing and the vertebrate nervous systemStructures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivityOligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intakeIncreased alternate splicing of Htr2c in a mouse model for Prader-Willi syndrome leads disruption of 5HT2C receptor mediated appetite.CAPS1 RNA Editing Promotes Dense Core Vesicle ExocytosisRegulation of alternative splicing by short non-coding nuclear RNAs.ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1.
P2860
Q26773402-7D011FEE-4C16-4282-AB85-0BD45C0F0AAAQ26776422-2333BF18-71F1-4B08-B64A-05C942FE0346Q26853110-22004E11-033B-4363-82F7-A9FC70C79F25Q26862159-466AC858-99F9-4D52-873C-454B37F5A229Q26991872-4421A288-F48E-4577-9589-91755592108EQ27014825-DDD5FB25-0776-41B0-BB0A-4E46F469B919Q28078569-82DF34E0-2579-4903-BB7D-05E87131E63DQ28272595-75723575-33A2-4FFE-905B-D925E19B2C05Q28603994-E0BC8795-5980-4290-A5AA-D192424C3765Q30465782-7D69C580-6861-48E5-ACC2-B4F0B951A3E5Q33747514-5C03033D-9810-4FDD-9FDE-400EE1618344Q33942739-2DDD5A6C-D117-40B1-BE61-C8FAF538E0A4Q34113945-DDAA3E14-FE04-4551-A260-E15C9F42843AQ34273564-35ED94B8-E793-49A0-A8BA-C3C4A0F36F68Q34326918-84630E8F-35DB-44B2-92C2-92BE22056EE1Q34368185-A5041A68-D786-4888-9A8B-3A80D4C197D0Q34389440-2AB78A6C-C39D-41DB-8660-394BEEB66680Q34808319-30852CF4-E9BD-493B-9AA1-86B56B0B739FQ35020416-D72EA367-AA19-43E0-BB6D-5BE19EEFFB55Q35098008-CEBD99E8-7AE7-4C19-A155-FDF1FAB41E2CQ35098779-0AED5AC5-C367-422B-85D1-493A71AEA485Q35123027-C9A42E1E-7DB8-478F-84CE-93DB6920FF06Q35148503-CC2A8BD9-A2FA-4AF3-ACC7-25AE414FC3E4Q35680723-319F8CA3-190A-4D00-9B2B-DDB53EFF37CCQ35842417-A512C047-A1D1-40C2-9AC5-BB5E98AB0B96Q35868044-9C6D384D-B47F-4196-9ACA-E8515761BB2CQ35963550-7530D2D6-352A-4359-B8E4-35571686B150Q36108397-F5900F6D-DFB4-4F95-A96C-DD879B7EE358Q36126606-4BFDD226-636E-43E0-B64F-C90E294BEB0FQ36341557-376496FB-6645-4CC4-8A1B-070458263186Q36550804-862AC6D5-2A9B-4023-B02D-87BD6E9264ACQ36718579-1250D0ED-2603-4956-BD0A-597372614C84Q36733507-3417037A-21A4-496A-B426-F0F34CEE708CQ36774926-118F0ADA-A165-4617-BB19-CC77D092ACE5Q37032837-9B79D744-B5E4-4070-9896-2CCE48F740BDQ37141372-8A9ECBE8-B911-48CB-97F5-4BF125E15B70Q37484458-FAC280AA-54D7-41DC-A20E-0D2056B563D1Q37544904-BEE5D2EB-F419-46AF-BE03-1A732964E4BAQ37775454-EA170794-FA88-4088-A680-6D286B478930Q37891173-014A8E7B-F0EE-4EE5-8F44-7A8B95EEADD0
P2860
Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@ast
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@en
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@nl
type
label
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@ast
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@en
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@nl
prefLabel
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@ast
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@en
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@nl
P2093
P2860
P1476
Mice with altered serotonin 2C ...... tics of Prader-Willi syndrome.
@en
P2093
Atheir I Abbas
Bryan L Roth
David L Hachey
David S Kump
Jennifer L Hood
Michael V Morabito
Michelle M Jacobs
Robert A Kesterson
Ronald B Emeson
P2860
P304
P356
10.1016/J.NBD.2010.04.004
P577
2010-04-13T00:00:00Z